期刊文献+

医保部门参与基本药物招标的思考 被引量:3

Thoughts on the Health Care Department to Participate in the Tendering of Essential Pharmaceuticals
下载PDF
导出
摘要 目的分析医保部门参与基本药物招标的积极作用,使得基本药物招标制度得到完善。方法运用相关利益者理论进行分析。结果与结论医保部门参与基本药物招标,有利于市场机制作用的发挥;有利于基本药物费用的控制;有利于基本药物带预算采购的实施。 Objective To evaluate the positive influence of health care department's participating in the tendering of essential pharmaceuticals in order to complete the tendering system of essential pharmaceuticals. Methods The stakeholder theory was utilized for the analysis. Results and Conclusion Health care department's participating in the tendering of essential pharmaceuticals was beneficial to exertion of market mechanism, control of the essential pharmaceutical fees and implementation of essential pharmaceutical purchasing with a budget.
作者 辛颖 陈永法
出处 《中国药事》 CAS 2013年第2期139-141,共3页 Chinese Pharmaceutical Affairs
关键词 医保部门 基本药物招标 health care department tendering of essential pharmaceuticals
  • 相关文献

参考文献7

二级参考文献44

共引文献68

同被引文献29

  • 1Carone G, Schwierz C, Xavier A.Cost-containment policiesin public pharmaceutical spending in the EU[M].Belgium:European Union, 2012: 33-37. 被引量:1
  • 2王 蕴.英国药品生产与流通体制现状、经验及启示[J].经济研究参考, 2014, (32): 86-112. 被引量:2
  • 3Leopold C, Habl C, Vogler S.Tendering of Pharmaceuticalsin EU Member States and EEA countries: Results from thecountry survey[R].Austrian: European Social Insurance Platform, 2008. 被引量:1
  • 4Kanavos P.Do generics offer significant savings to the UKNational Health Service?[J].Curr Med Res Opin, 2007, 23:105-116. 被引量:1
  • 5Lybecker KM.The bulk purchase of pharmaceuticals: theexperiences of the United States, Europe, and New Zealand[R].Colorado: Fraser Institute, 2013. 被引量:1
  • 6Va n d o r o s S, St a rg a r d t T.Re f o rms i n t h e Gr e e kpharmaceutical market during the financial crisis[J].HealthPolicy, 2013, 109(1): 1-6. 被引量:1
  • 7Panos K, Liz S, Sotiri V.Tender systems for outpatientpharmaceuticals in the European Union: Evidence from theNetherlands, Germany and Belgium[R].London: European Commission, 2009. 被引量:1
  • 8Dylst P, Vulto A, Simoens S.Tendering for outpatientprescription pharmaceuticals: What can be learned fromcurrent practices in Europe?[J].Health Policy, 2011,101(2): 146-152. 被引量:1
  • 9Mackay P.Is PHARMAC's sole-supply tendering policyharming the health of New Zealanders?[J].New ZealandMed J, 2005, 118(1214): 1433. 被引量:1
  • 10Schulenburg KP.The effects of drug market regulation onpharmaceutical prices in Europe: overview and evidencefrom the market of ACE inhibitors[J].Health EconomicsRev, 2011, 1(18): 1-8. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部